Navigation Links
The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
Date:6/24/2009

Winners awarded with trip to California to participate in the Foundation's Orange County Take Steps event

NEW YORK, June 24 /PRNewswire/ -- The Crohn's & Colitis Foundation, in partnership with Procter & Gamble Pharmaceuticals (P&GP), announces six winners from the second annual Celebrating UC Success essay contest. Established in December 2007, Celebrating UC Success is a program that honors people who have found personal ways to manage their ulcerative colitis (UC), a form of inflammatory bowel disease. The program highlights their successes to educate and inspire other patients and UC supporters. This year's winners are being awarded a trip for two to participate in the Foundation's Take Steps walk in Orange County, California on June 28, where they will be able to meet with others affected by UC and take part in Take Steps festivities.

Building on last year's contest, which accepted essays describing patient success over the challenges of UC, this year's contest called for UC Quick Tips -- specific, "tried and true" lifestyle tips that people affected by UC have discovered through experience to help manage their disease on a daily basis. This year's contest accepted essays and video submissions, with a goal to identify ways to help patients take steps to potentially achieve their own success.

"Because UC impacts patients' lives on a daily basis, it is important that they are armed with simple techniques that can help make each day a little bit easier," said Kimberly Frederick, Vice President of Patient and Professional Services for the Foundation. "We recognize that many UC patients are able to live full, rich lives despite the challenges that accompany their disease. Through this year's contest, we wanted these patients to share their knowledge and learnings from their experiences to help others achieve daily success with their disea
'/>"/>

SOURCE Crohn's & Colitis Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Mouse Study Gives Clues to Colitis
2. New therapeutic targets in the treatment of ulcerative colitis
3. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
4. Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives
5. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
6. Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis
7. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
8. A rare case of ischemic colitis caused by chronic venous insufficiency
9. Study underway to find an alternative cure for Crohns disease and ulcerative colitis
10. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
11. Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... randomized controlled trials (RCTs) are critical for determining ... Canada provides scant support for these studies compared ... CMAJ ( Canadian Medical Association Journal ... Hamilton Health Sciences, Hamilton, Ontario, with Dr. John ... analysis and appendix that Canada should provide better ...
(Date:5/22/2012)... , , TUESDAY, May 22 (HealthDay News) -- New research ... of snoring and daytime sleepiness, might also cut down ... -- the risk of developing high blood pressure. ... of high blood pressure in two groups with sleep ... CPAP, for either about four or 11 years. CPAP ...
(Date:5/22/2012)... uproar that began last year when the U.S. Preventive ... offer regular prostate-cancer tests to healthy men continued this ... Overall, they stuck to their guns, stating that a ... the PSA test, causes more harm than good ... dangerous, treatments. , But many people simply don,t believe ...
(Date:5/22/2012)... at Barrow Neurological Institute at St. Joseph,s Hospital ... the public perceives some magic tricks in recent ... tactics, marketing and sports. , Susana Martinez-Conde, PhD, ... Macknik, PhD, of Barrow,s Laboratory of Behavioral Neurophysiology ... and illusions. Their most recent original research projects, ...
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 ... no longer recommends that men routinely undergo prostate ... should ask their doctors for the exam if ... Urologists and cancer experts dismissed the idea that ... the PSA test will set a man,s personal ...
Breaking Medicine News(10 mins):Health News:Canada should significantly increase its funding of randomized clinical trials 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:Barrow researchers use magic for discoveries 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 2Health News:Men Can Still Ask for PSA Test, and Some Should, Doctors Say 3
... scientists and clinicians to present advances,in CF research and ... meeting will draw more than 3,000 cystic fibrosis experts ... 3 - 6, 2007 to present the,latest information and ... The 21st annual North American Cystic Fibrosis Conference is ...
... Bristol-Myers Squibb,(NYSE: BMY ) announced today that ... Development organization as senior vice president, External,Science, Technology ... Sigal,chief scientific officer and president, Research and Development. ... R&D organization at this critical,juncture for Bristol-Myers Squibb, ...
... leading cause of parasitic infections in U.S. , THURSDAY, ... genome of the intestinal parasite Giardia lamblia , ... in the United States. , That makes giardia the ... in the country, experts note. , People contract Giardia ...
... the United States have determined that young adolescents who see ... To combat smoking among youth, public health groups have called ... A new study from New Zealand, however, calls that strategy ... the intended effect of putting such movies out of reach ...
... ... Executives to Provide Leadership, CHICAGO, Sept. 27 ... investment firms, has established an,Advisory Board to provide unbiased ... business partnerships. John H. Driscoll,Alter+Care President, announced the Alter+Care ...
... Complicated daily regimens lower their quality of life, ... For some people with diabetes, the burden of adhering ... their diabetes-related health complications, a U.S. study finds. , ... 700 adults with type 2 diabetes. , As reported ...
Other Medicine News:Health News:Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting 2Health News:Jeremy Levin Joins Bristol-Myers Squibb as Senior Vice President of External Science, Technology and Licensing 2Health News:Scientists Map Intestinal Bug's Genome 2Health News:R rating might be unlikely to affect teens exposure to smoking in movies 2Health News:Alter+Care Creates the Advisory Board 2Health News:Alter+Care Creates the Advisory Board 3Health News:For Some, Diabetes Care Worse Than Illness Itself 2
(Date:5/22/2012)... Vanda Pharmaceuticals Inc. (NASDAQ: VNDA ), ... commercialization of products for central nervous system disorders, ... at the Society for Research on Biological Rhythms ... The first poster entitled Pleiomorphic Expression of ... insight into the challenges faced by individuals suffering ...
(Date:5/22/2012)... ALLEGAN, Mich., May 22, 2012  Perrigo Company ... final approval from the U.S. Food and Drug ... for butoconazole nitrate 2% vaginal cream, the generic ... submit a substantially complete ANDA with a paragraph ... marketing exclusivity. Perrigo is working exclusively with KV Pharmaceutical ...
(Date:5/22/2012)... Generics, a division of Prodigy Health Supplier Corporation ... generic equivalent of the branded drug Camptosar by ... Laboratories to develop a portfolio of oncology products. ... developed through the partnership that will add consistent ... market, which has experienced record levels of shortages ...
Breaking Medicine Technology:Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 2Vanda Pharmaceuticals Inc. Presents Scientific Posters at Society for Research on Biological Rhythms (SRBR) Annual Meeting 3Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 2Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 1GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 2GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 3GeoVax Initiates Third Site For Therapeutic Testing of Its HIV Vaccine 19815 4ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 1ULURU Inc Announces the Engagement of Gilford Securities Incorporated to Serve as the Companys Financial Advisor 18324 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 1MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 2MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 3MAP Pharmaceuticals to Present Data on LEVADEX AE at the 15th Congress of the International Headache Society 18320 4
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: